(S,R,S)-AHPC-C4-NH2 is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). These molecules are designed to selectively degrade specific proteins within cells, offering a promising approach for treating diseases such as cancer, neurodegenerative disorders, and autoimmune conditions. The compound serves as a key ligand that binds to E3 ubiquitin ligases, facilitating the ubiquitination and subsequent degradation of target proteins. Its application extends to research and drug discovery, where it aids in understanding protein function and identifying potential therapeutic targets. Additionally, it is employed in the synthesis of novel compounds for studying cellular pathways and protein interactions, contributing to advancements in precision medicine.